Indication: Sickle Cell Disease (SCD)

HbO2 Hemopure – HBOC-201 (IND# 18513)

Hyperhemolytic crisis

Drug Study - Emergency Use IND

Principal Investigator: Terence Hadley, M.D.
Norton Cancer Institute

Sponsor: HbO2 Therapeutics LLC

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.